Company
History
2026
- Built AI toxicity prediction software for organoid images
- Selected for the Dassault Systèmes global collaboration program
- Filed patent application for the Port Pocket 3D cell culture kit
- Moved into J Bio Valley, Jeonbuk State
- Selected for the NRF Early-Career Researcher Program
- Selected for the Pre-Startup Package (Deep-tech track)
- Selected for the Jeonbuk K-Bio Health Regional Center program
2025
- Corporate R&D department certified (KOITA)
- Filed two patent applications: AI spheroid analysis system and multi-disease spheroid kit
- Opened R&D center at the VHS Medical Center research institute
- Research agreement with Seoul National University (linked with Seoul Shinsegae Eye Center bio-imaging center)
- AiderBio Co., Ltd. founded
Roadmap
2026
Prototype validation
Mass-production prototype, kit optimization and test reports
2027
Launch in Korea
OrganoKit launch, production setup, retina and cornea models, AI analysis service
2028
Multi-organ and certification
Automated multi-organ analysis prototype, CE and FDA preparation
2029
Global expansion
NAM data submission for AI models, overseas distribution